Newsfeeds Archive - Page 3 of 4 - Spark Newswire

Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Read More

4 minute read

Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

June 7, 2:02 PM

Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for political campaigns.

Read More

1 minute read

Calavo Growers, Mondee Holdings And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

June 7, 6:38 AM

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Read More

1 minute read

Cogent Biosciences Priced Upsized 12.5M Share Public Offering of Shares of Common Stock @$12/Share

By Charles Gross

June 7, 5:35 AM

Cogent Biosciences, Inc. (NASDAQ:COGT) announced the pricing of its previously announced underwritten public offering of 12,500,000 shares of its common stock, offered at a public offering price

Read More

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For April 28, 2023

By Benzinga Insights

April 28, 11:00 AM

Upgrades Deutsche Bank upgraded the previous rating for Old Dominion Freight Line Inc (NASDAQ:ODFL) from Hold to Buy.…

Read More

2 minute read

Analyst Ratings

Analyst Ratings for Cogent Biosciences

By Benzinga Insights

April 28, 8:09 AM

Cogent Biosciences (NASDAQ:COGT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

Read More

2 minute read

Analyst Ratings

Expert Ratings for Cogent Biosciences

By Benzinga Insights

March 27, 11:00 AM

Analysts have provided the following ratings for Cogent Biosciences (NASDAQ:COGT) within the last quarter: Bullish Somewhat Bullish Indifferent…

Read More

2 minute read

Analyst Ratings

Expert Ratings for Cogent Biosciences

By Benzinga Insights

March 27, 11:00 AM

Analysts have provided the following ratings for Cogent Biosciences (NASDAQ:COGT) within the last quarter: Bullish Somewhat Bullish Indifferent…

Read More

2 minute read

Analyst Ratings

4 Analysts Have This to Say About Cogent Biosciences

By Benzinga Insights

March 27, 8:03 AM

Cogent Biosciences (NASDAQ:COGT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

Read More

1 minute read

Needham Maintains Buy on Cogent Biosciences, Lowers Price Target to $23

By Benzinga Newsdesk

March 15, 5:23 AM

Needham analyst Ami Fadia maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and lowers the price target from $24 to $23.

Read More

1 minute read

SVB Leerink Maintains Outperform on Cogent Biosciences, Raises Price Target to $20

By Benzinga Newsdesk

January 5, 7:58 AM

SVB Leerink analyst Andrew Berens maintains Cogent Biosciences (NASDAQ:COGT) with a Outperform and raises the price target from $18 to $20.